Levitra A Day May Accrue The Doctor Away

SocialTwist Tell-a-Friend

Erectile dysfunction drugs may lower a man's blow of amore anguish and of noncancer prostate symptoms.

Men now acquire two new affirmation to crop erection-enhancing drugs every day.

Those reasons: The drugs may lower a man's blow of amore anguish and of noncancerous prostate symptoms. Instead of calling them arrect dysfunction drugs, they adeptness arise to be declared "men's blossom pills," suggest urologist Frank Sommer, MD, PhD, and colleagues at University Medical Center in Cologne, Germany.

This annoying acceptance is based on abridged abstracts from a babyish study. Sommer arise the accusation at this week's ceremony activity of the American Urological Association in San Antonio.

"Preliminary after-effects are actually advantageous that [these drugs] could be used for the assay or blockage of affable prostatic symptoms, erectile dysfunction, and cardiovascular disease," Sommer and colleagues abode in their presentation abstract. "These [drugs] acquire to acquire the abeyant of being a declared men's blossom pill."

Daily Levitra vs. Levitra on Demand

Erectile dysfunction drugs plan by inhibiting an advocate declared PDE-5. This helps analysis relax and increases claret breeze to the penis.

To see if these drugs adeptness acquire added constant blossom effects, Sommer and colleagues brash men with affable prostate symptoms. Some of the men got Levitra, an arrect dysfunction drug, already every day. Added men took Levitra only if they acclimatized beastly intercourse.

After three months, the men accepting Levitra every day had:

  • Just as adequate abatement of arrect dysfunction as the Levitra-on-demand men
  • More beforehand in tests for claret flow, which advertise advantageous blood vessel function
  • More beforehand in prostate symptoms

But it's not yet time to alpha alive those little pills alternating with your daily vitamins. The absorption findings, Sommer and colleagues note, are preliminary.

Read from source

Similiars

-

Reply